A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 18, 2018

Study Completion Date

February 18, 2018

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG

Tocilizumab

Trial Locations (1)

Papworth Hospital NHS Foundation Trust, Cambridge

All Listed Sponsors

collaborator

Roche Pharma AG

INDUSTRY

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Papworth Hospital NHS Foundation Trust

OTHER_GOV

NCT02676947 - A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter